Edition:
United States

Insider Trading: Sangamo BioSciences Inc (SGMO.O)

SGMO.O on Nasdaq

3.25USD
1:56pm EST
Change (% chg)

$0.55 (+20.37%)
Prev Close
$2.70
Open
$2.70
Day's High
$3.35
Day's Low
$2.70
Volume
1,180,663
Avg. Vol
953,049
52-wk High
$9.83
52-wk Low
$2.65

All Insider Trades
Trading Date Name Title Type Shares Traded Price
12 Jun 2016

Lanphier (Edward O II)

Director Sell 15,658 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 21,741 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 21,741 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 16,107 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 9,395 $6.23
6 Jun 2016

Lanphier (Edward O II)

Director Gift 50,000 $0.00
10 Mar 2016

Lanphier (Edward O II)

Director Gift 8,000 $0.00
11 Dec 2015

Nichol (Geoffrey M)

Officer Sell 4,384 $8.68
11 Dec 2015

Ando (Dale Genji)

Officer Sell 4,000 $8.68
11 Dec 2015

Lanphier (Edward O II)

Chief Executive Officer Sell 13,045 $8.68
11 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Sell 6,087 $8.68
10 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Sell 6,522 $8.68
10 Dec 2015

Ando (Dale Genji)

Officer Sell 4,348 $8.68
10 Dec 2015

Lanphier (Edward O II)

Chief Executive Officer Sell 21,741 $8.68
10 Dec 2015

Nichol (Geoffrey M)

Officer Sell 4,697 $8.68
7 Dec 2015

Lanphier (Edward O II)

Chief Executive Officer Buy 125,000 $0.00
7 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Buy 37,500 $0.00
7 Dec 2015

Ando (Dale Genji)

Officer Buy 25,000 $0.00
7 Dec 2015

Nichol (Geoffrey M)

Officer Buy 37,500 $0.00
6 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Sell 7,060 $9.69
6 Dec 2015

Nichol (Geoffrey M)

Officer Sell 6,889 $9.69
6 Dec 2015

Lanphier (Edward O II)

Chief Executive Officer Gift 13,000 $0.00
6 Dec 2015

Lanphier (Edward O II)

Chief Executive Officer Sell 31,308 $9.69
6 Dec 2015

Ando (Dale Genji)

Officer Sell 6,087 $9.69
14 Jul 2015

Lanphier (Edward O II)

Chief Executive Officer Sell 25,000 $10.43

Institutional Holders

% Shares Owned: 63.55%
# of Holders: 178
Total Shares Held: 44,883,778
3 Mo. Net Change: -2,144,534
# New Positions: 16
# Closed Positions: 25
# Increased Positions: 73
# Reduced Positions: 57
# Net Buyers: 16

Officers & Directors

Name Age Since Current Position

Edward Lanphier

58 2016 Non-Executive Chairman of the Board

Alexander Macrae

2016 President, Chief Executive Officer, Director

H. Ward Wolff

67 2007 Chief Financial Officer, Principal Financial and Accounting Officer, Executive Vice President

Dale Ando

60 2004 Vice President - Therapeutic Development, Chief Medical Officer

H. Stewart Parker

59 2014 Director

William Ringo

70 2016 Director

Stephen Dilly

55 2010 Independent Director

John Larson

80 1996 Independent Director

Steven Mento

63 2005 Independent Director

Saira Ramasastry

39 2012 Independent Director

Elizabeth Wolffe

IR Contact Officer, Corporate Communications